Key Takeaway
Looking for a MEDVi alternative in 2026? We compare the top physician-supervised GLP-1 and peptide therapy programs worth considering.
MEDVi has built a following in the GLP-1 telehealth space, and for good reason. Their platform connects patients with licensed providers, handles prescriptions, and ships compounded medications. It works for a lot of people.
But not everyone. Maybe you have been waiting too long for provider responses. Maybe the pricing doesn't fit your budget anymore. Maybe you want more hands-on clinical oversight or access to peptide therapies beyond semaglutide. Whatever brought you here, you aren't alone in looking for a MEDVi alternative in 2026.
We evaluated the leading telehealth GLP-1 programs across pricing, clinical care, medication options, and patient experience to help you find the right fit.
Why People Look for MEDVi Alternatives
MEDVi patients typically start exploring other options for a handful of recurring reasons:
- Limited provider interaction. Some patients feel the consultations are too brief or infrequent for the complexity of GLP-1 therapy.
- Pricing concerns. As patients titrate to higher doses, monthly costs can climb in ways they did not anticipate at enrollment.
- Narrow medication options. Patients interested in tirzepatide, BPC-157, or other peptide therapies may find MEDVi's formulary limiting.
- Customer service friction. Billing questions, shipping delays, and difficulty reaching support staff come up frequently in patient reviews.
- Desire for more personalized protocols. Cookie-cutter dosing schedules don't work for everyone, and some patients want a provider who adjusts based on their individual response.
None of these issues mean MEDVi is a bad program. They mean it isn't the right program for everyone.
Top MEDVi Alternatives in 2026
1. FormBlends
FormBlends is a physician-supervised telehealth platform specializing in compounded GLP-1 and peptide therapy. What sets it apart from MEDVi is the depth of clinical engagement. Every patient works directly with a licensed physician who builds and adjusts their protocol based on individual response, lab work, and treatment goals.
View data table
| Category | Overall Value Score | Detail |
|---|---|---|
| FormBlends | 92 | From $299/mo, physician-led |
| Hims/Hers | 78 | Consumer brand, varies |
| Ro | 75 | Telehealth platform |
| Calibrate | 70 | Metabolic health focus |
The medication options are broader than most competitors. Beyond compounded semaglutide ($199/month) and tirzepatide ($249/month), FormBlends offers peptide therapies like BPC-157 for recovery and gut health. For patients who felt boxed in by MEDVi's formulary, that flexibility matters.
Pricing is transparent and all-inclusive. There are no hidden consult fees, no surprise charges at higher doses, and no long-term contracts.
Pros:
- Direct physician supervision with personalized dosing
- Broad formulary including GLP-1s and peptide therapies
- Transparent, flat-rate monthly pricing
- No long-term commitment required
Cons:
- Not the cheapest option available
- Newer brand with less mainstream recognition
2. Ro Body
Ro brings strong medical infrastructure to the GLP-1 space. Their in-house pharmacy and lab monitoring protocols give patients a clinical experience that goes beyond what most telehealth platforms provide. If your primary concern with MEDVi was the quality of medical oversight, Ro is worth evaluating.
Starting prices are competitive at $149/month for compounded semaglutide, though costs increase as you move to higher doses. The program is physician-led and data-driven, with dosing adjustments based on objective lab results rather than patient self-reporting alone.
Pros:
- Lab monitoring included in the program
- In-house pharmacy for quality control
- Strong medical oversight
Cons:
- Higher-dose pricing can add up
- Not available in every state
- No peptide therapy options
3. Henry Meds
If price is your primary reason for leaving MEDVi, Henry Meds deserves a look. At $149/month for compounded semaglutide with no separate consult fees, it's one of the most affordable physician-supervised GLP-1 programs available. The tradeoff is a more simplified (some would say basic) clinical experience.
Pros:
- $149/month all-in pricing
- Simple enrollment process
- No hidden fees
Cons:
- Less personalized medical oversight
- No lab monitoring
- Limited medication options
4. Hims/Hers
Hims (and its sister brand Hers) operates at massive scale, which translates to reliable supply chains and a polished user experience. For patients who left MEDVi due to shipping delays or platform usability issues, Hims offers a smoother day-to-day experience. Clinical depth isn't the strength here, but operational reliability is.
Pros:
- Well-established platform with reliable logistics
- Competitive pricing
- Strong mobile app experience
Cons:
- High-volume model means less individual attention
- Limited peptide options
- Provider interactions can feel transactional
5. SkinnyRx
SkinnyRx focuses specifically on weight loss medications and keeps its program lean. Pricing is competitive, the enrollment process is quick, and the platform doesn't try to be everything to everyone. If you want a focused GLP-1 program without the extras, SkinnyRx is a solid alternative.
Pros:
- Focused exclusively on weight loss
- Fast enrollment and shipping
- Competitive pricing
Cons:
- No peptide therapy options
- Less clinical depth than physician-supervised programs
- Smaller support team
MEDVi Alternatives Comparison Table
| Program | Monthly Cost | Medications | Physician Supervision | Peptide Therapy | Contracts |
|---|---|---|---|---|---|
| FormBlends | $199+ | Semaglutide, tirzepatide, peptides | Direct physician oversight | Yes | None |
| Ro Body | $149+ | Semaglutide, tirzepatide | Lab-based monitoring | No | None |
| Henry Meds | $149 | Semaglutide | Monthly check-ins | No | None |
| Hims/Hers | $149+ | Semaglutide, tirzepatide | Provider consultations | No | None |
| SkinnyRx | $149+ | Semaglutide | Basic oversight | No | None |
Who Should Consider Switching from MEDVi
Switching GLP-1 providers mid-treatment isn't something to do on a whim. If your current protocol is working and your side effects are manageable, stability has real value. But certain situations make a switch worth considering:
Not sure which GLP-1 is right for you?
Take a 2-minute assessment and get a personalized recommendation from a licensed physician.
Take the Assessment →- You want more clinical involvement. If you feel like your MEDVi provider isn't adjusting your protocol based on how you're actually responding, a program with deeper physician engagement (like FormBlends or Ro) may produce better outcomes.
- You need peptide therapy options. If you're interested in BPC-157 or other therapeutic peptides alongside your GLP-1, you'll need a provider with a broader formulary.
- The cost isn't sustainable. If your monthly spend has climbed beyond what you budgeted, programs like Henry Meds offer similar medication at lower price points.
- You're having service issues. Chronic shipping delays, billing errors, or difficulty reaching support are legitimate reasons to move your care elsewhere.
Frequently Asked Questions
Can I switch from MEDVi to another provider without a gap in treatment?
Yes, in most cases. The best approach is to enroll with your new provider before your current MEDVi prescription runs out. Most telehealth GLP-1 programs can get you started within a few days of your initial consultation, so there should be minimal or no gap in your medication.
Will I need to start over at a low dose if I switch providers?
Not necessarily. A good provider will review your treatment history and continue from your current dose if it's appropriate. Be prepared to share your dosing history and any relevant lab work with your new provider.
Are compounded GLP-1 medications the same across providers?
Compounded medications can vary by pharmacy. Different providers work with different 503B compounding pharmacies, and quality standards, formulations, and concentrations may differ. Programs that work with FDA-registered compounding facilities and maintain strong pharmacy relationships tend to deliver more consistent results.
Is it safe to switch GLP-1 providers?
Switching providers is safe as long as your new physician has a complete picture of your treatment history. The medication itself doesn't change. what changes is the clinical team managing your care. If anything, moving to a provider with better oversight can improve your safety profile.
Do I need to cancel MEDVi before signing up elsewhere?
You should cancel your MEDVi subscription to avoid being billed, but you don't need to cancel before enrolling with a new provider. Start the new program first, confirm your medication is on the way, and then cancel MEDVi to avoid a gap.
Key Points
MEDVi works for many patients, but the GLP-1 telehealth market in 2026 offers enough strong alternatives that you don't have to settle for a program that isn't meeting your needs. Whether you prioritize cost, clinical depth, or access to peptide therapies, there's a program built for what you're looking for.
Ready to explore a physician-supervised alternative? FormBlends offers personalized GLP-1 and peptide therapy with direct physician oversight, transparent pricing, and no long-term contracts. Start your consultation today.